HEADER HYDROLASE/HYDROLASE INHIBITOR 08-MAY-14 4PI3 TITLE CRYSTAL STRUCTURE ANALYSIS OF CRUZAIN BOUND TO VINYL SULFONE ANALOG OF TITLE 2 WRR-483 (WRR-666) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CRUZIPAIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 122-337; COMPND 5 SYNONYM: CRUZAINE,MAJOR CYSTEINE PROTEINASE; COMPND 6 EC: 3.4.22.51; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA CRUZI; SOURCE 3 ORGANISM_TAXID: 5693; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS CYSTEIN PROTEASE, CRUZAIN, CHAGAS DISEASE, COVALENT INHIBITOR, VINYL KEYWDS 2 SULFONE DERIVATIVE, ANALOGE OF WRR-483, HYDROLASE-HYDROLASE KEYWDS 3 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.TOCHOWICZ,J.H.MCKERROW REVDAT 4 27-SEP-23 4PI3 1 REMARK REVDAT 3 10-FEB-16 4PI3 1 JRNL REVDAT 2 11-MAR-15 4PI3 1 REMARK DBREF SEQADV SEQRES REVDAT 1 12-NOV-14 4PI3 0 JRNL AUTH B.D.JONES,A.TOCHOWICZ,Y.TANG,M.D.CAMERON,L.I.MCCALL, JRNL AUTH 2 K.HIRATA,J.L.SIQUEIRA-NETO,S.L.REED,J.H.MCKERROW,W.R.ROUSH JRNL TITL SYNTHESIS AND EVALUATION OF OXYGUANIDINE ANALOGUES OF THE JRNL TITL 2 CYSTEINE PROTEASE INHIBITOR WRR-483 AGAINST CRUZAIN. JRNL REF ACS MED.CHEM.LETT. V. 7 77 2016 JRNL REFN ISSN 1948-5875 JRNL PMID 26819670 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00336 REMARK 2 REMARK 2 RESOLUTION. 1.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 86.52 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 109411 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5804 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.27 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.30 REMARK 3 REFLECTION IN BIN (WORKING SET) : 7694 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.18 REMARK 3 BIN R VALUE (WORKING SET) : 0.4270 REMARK 3 BIN FREE R VALUE SET COUNT : 391 REMARK 3 BIN FREE R VALUE : 0.4530 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3184 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 459 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.98 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.75000 REMARK 3 B22 (A**2) : 1.41000 REMARK 3 B33 (A**2) : -0.80000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.16000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.045 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.048 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.034 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.827 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.972 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.965 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3356 ; 0.027 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4592 ; 2.506 ; 1.940 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 428 ; 6.596 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 136 ;40.977 ;25.735 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 462 ;10.353 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ;20.737 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 498 ; 0.163 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2586 ; 0.015 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 4PI3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAY-14. REMARK 100 THE DEPOSITION ID IS D_1000201377. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-NOV-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.3.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1159 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 114913 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.270 REMARK 200 RESOLUTION RANGE LOW (A) : 63.620 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.08500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3KKU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M MAGNESIUM ACETATE, 30% (+/-)-2 REMARK 280 -METHYL-2,4-PENTANEDIOL AND 0.1 M SODIUM CACODYLATE, PH 6.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 66.96150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.33450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 66.96150 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.33450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 GLY B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 405 O HOH B 582 1.84 REMARK 500 O HOH A 408 O HOH A 448 1.86 REMARK 500 O HOH A 447 O HOH A 620 2.06 REMARK 500 O HOH A 449 O HOH A 587 2.11 REMARK 500 O HOH A 537 O HOH A 567 2.12 REMARK 500 O HOH A 501 O HOH A 640 2.18 REMARK 500 O HOH A 585 O HOH A 618 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 401 O HOH B 422 1565 1.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS B 115 CG HIS B 115 CD2 0.059 REMARK 500 CYS B 203 CB CYS B 203 SG -0.108 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 8 NE - CZ - NH1 ANGL. DEV. = -3.4 DEGREES REMARK 500 ARG A 10 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 ASP A 57 CB - CG - OD1 ANGL. DEV. = 9.3 DEGREES REMARK 500 ASP A 121 CB - CG - OD1 ANGL. DEV. = 6.5 DEGREES REMARK 500 ASP A 161 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 TYR A 193 CB - CG - CD1 ANGL. DEV. = -3.8 DEGREES REMARK 500 ARG B 10 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ASP B 87 CB - CG - OD2 ANGL. DEV. = 7.1 DEGREES REMARK 500 TYR B 89 CB - CG - CD1 ANGL. DEV. = -4.9 DEGREES REMARK 500 ASP B 161 CB - CG - OD1 ANGL. DEV. = 7.4 DEGREES REMARK 500 TYR B 169 CB - CG - CD1 ANGL. DEV. = -3.8 DEGREES REMARK 500 ASP B 171 CB - CG - OD1 ANGL. DEV. = 7.8 DEGREES REMARK 500 ARG B 195 NE - CZ - NH2 ANGL. DEV. = 4.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 2 153.91 -49.46 REMARK 500 THR A 185 167.22 70.10 REMARK 500 TYR B 89 69.64 -158.25 REMARK 500 ALA B 92 13.74 -140.57 REMARK 500 THR B 185 167.55 76.52 REMARK 500 GLU B 208 71.68 -150.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 2V5 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide 2V5 B 301 and CYS B REMARK 800 25 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3LXS RELATED DB: PDB REMARK 900 RELATED ID: 2OZ2 RELATED DB: PDB REMARK 900 RELATED ID: 4XUI RELATED DB: PDB DBREF 4PI3 A 0 215 UNP P25779 CYSP_TRYCR 122 337 DBREF 4PI3 B 0 215 UNP P25779 CYSP_TRYCR 122 337 SEQRES 1 A 216 GLY ALA PRO ALA ALA VAL ASP TRP ARG ALA ARG GLY ALA SEQRES 2 A 216 VAL THR ALA VAL LYS ASP GLN GLY GLN CYS GLY SER CYS SEQRES 3 A 216 TRP ALA PHE SER ALA ILE GLY ASN VAL GLU CYS GLN TRP SEQRES 4 A 216 PHE LEU ALA GLY HIS PRO LEU THR ASN LEU SER GLU GLN SEQRES 5 A 216 MET LEU VAL SER CYS ASP LYS THR ASP SER GLY CYS SER SEQRES 6 A 216 GLY GLY LEU MET ASN ASN ALA PHE GLU TRP ILE VAL GLN SEQRES 7 A 216 GLU ASN ASN GLY ALA VAL TYR THR GLU ASP SER TYR PRO SEQRES 8 A 216 TYR ALA SER GLY GLU GLY ILE SER PRO PRO CYS THR THR SEQRES 9 A 216 SER GLY HIS THR VAL GLY ALA THR ILE THR GLY HIS VAL SEQRES 10 A 216 GLU LEU PRO GLN ASP GLU ALA GLN ILE ALA ALA TRP LEU SEQRES 11 A 216 ALA VAL ASN GLY PRO VAL ALA VAL ALA VAL ASP ALA SER SEQRES 12 A 216 SER TRP MET THR TYR THR GLY GLY VAL MET THR SER CYS SEQRES 13 A 216 VAL SER GLU GLN LEU ASP HIS GLY VAL LEU LEU VAL GLY SEQRES 14 A 216 TYR ASN ASP SER ALA ALA VAL PRO TYR TRP ILE ILE LYS SEQRES 15 A 216 ASN SER TRP THR THR GLN TRP GLY GLU GLU GLY TYR ILE SEQRES 16 A 216 ARG ILE ALA LYS GLY SER ASN GLN CYS LEU VAL LYS GLU SEQRES 17 A 216 GLU ALA SER SER ALA VAL VAL GLY SEQRES 1 B 216 GLY ALA PRO ALA ALA VAL ASP TRP ARG ALA ARG GLY ALA SEQRES 2 B 216 VAL THR ALA VAL LYS ASP GLN GLY GLN CYS GLY SER CYS SEQRES 3 B 216 TRP ALA PHE SER ALA ILE GLY ASN VAL GLU CYS GLN TRP SEQRES 4 B 216 PHE LEU ALA GLY HIS PRO LEU THR ASN LEU SER GLU GLN SEQRES 5 B 216 MET LEU VAL SER CYS ASP LYS THR ASP SER GLY CYS SER SEQRES 6 B 216 GLY GLY LEU MET ASN ASN ALA PHE GLU TRP ILE VAL GLN SEQRES 7 B 216 GLU ASN ASN GLY ALA VAL TYR THR GLU ASP SER TYR PRO SEQRES 8 B 216 TYR ALA SER GLY GLU GLY ILE SER PRO PRO CYS THR THR SEQRES 9 B 216 SER GLY HIS THR VAL GLY ALA THR ILE THR GLY HIS VAL SEQRES 10 B 216 GLU LEU PRO GLN ASP GLU ALA GLN ILE ALA ALA TRP LEU SEQRES 11 B 216 ALA VAL ASN GLY PRO VAL ALA VAL ALA VAL ASP ALA SER SEQRES 12 B 216 SER TRP MET THR TYR THR GLY GLY VAL MET THR SER CYS SEQRES 13 B 216 VAL SER GLU GLN LEU ASP HIS GLY VAL LEU LEU VAL GLY SEQRES 14 B 216 TYR ASN ASP SER ALA ALA VAL PRO TYR TRP ILE ILE LYS SEQRES 15 B 216 ASN SER TRP THR THR GLN TRP GLY GLU GLU GLY TYR ILE SEQRES 16 B 216 ARG ILE ALA LYS GLY SER ASN GLN CYS LEU VAL LYS GLU SEQRES 17 B 216 GLU ALA SER SER ALA VAL VAL GLY HET 2V5 A 301 42 HET 2V5 B 301 42 HETNAM 2V5 N-[(2S)-5-(CARBAMIMIDAMIDOOXY)-1-OXO-1-{[(1E,3S)-5- HETNAM 2 2V5 PHENYL-1-(PHENYLSULFONYL)PENT-1-EN-3-YL]AMINO}PENTAN- HETNAM 3 2V5 2-YL]-4-METHYLPIPERAZINE-1-CARBOXAMIDE FORMUL 3 2V5 2(C29 H41 N7 O5 S) FORMUL 5 HOH *459(H2 O) HELIX 1 AA1 SER A 24 ALA A 41 1 18 HELIX 2 AA2 SER A 49 ASP A 57 1 9 HELIX 3 AA3 SER A 61 GLY A 65 5 5 HELIX 4 AA4 LEU A 67 ASN A 79 1 13 HELIX 5 AA5 ASP A 121 GLY A 133 1 13 HELIX 6 AA6 ALA A 141 MET A 145 5 5 HELIX 7 AA7 ASN A 201 VAL A 205 5 5 HELIX 8 AA8 SER B 24 ALA B 41 1 18 HELIX 9 AA9 SER B 49 ASP B 57 1 9 HELIX 10 AB1 SER B 61 GLY B 65 5 5 HELIX 11 AB2 LEU B 67 ASN B 79 1 13 HELIX 12 AB3 ASP B 121 GLY B 133 1 13 HELIX 13 AB4 ALA B 141 MET B 145 5 5 HELIX 14 AB5 ASN B 201 VAL B 205 5 5 SHEET 1 AA1 5 ALA A 4 ASP A 6 0 SHEET 2 AA1 5 HIS A 162 ASN A 170 -1 O TYR A 169 N VAL A 5 SHEET 3 AA1 5 VAL A 135 VAL A 139 -1 N VAL A 135 O LEU A 166 SHEET 4 AA1 5 ALA A 209 VAL A 213 -1 O SER A 210 N ALA A 136 SHEET 5 AA1 5 GLY A 114 GLU A 117 -1 N VAL A 116 O SER A 211 SHEET 1 AA2 5 ALA A 4 ASP A 6 0 SHEET 2 AA2 5 HIS A 162 ASN A 170 -1 O TYR A 169 N VAL A 5 SHEET 3 AA2 5 TYR A 177 LYS A 181 -1 O LYS A 181 N LEU A 165 SHEET 4 AA2 5 TYR A 193 ALA A 197 -1 O ILE A 196 N TRP A 178 SHEET 5 AA2 5 VAL A 151 MET A 152 1 N MET A 152 O ALA A 197 SHEET 1 AA3 2 ALA A 82 TYR A 84 0 SHEET 2 AA3 2 VAL A 108 THR A 111 -1 O GLY A 109 N VAL A 83 SHEET 1 AA4 5 ALA B 4 ASP B 6 0 SHEET 2 AA4 5 HIS B 162 ASN B 170 -1 O TYR B 169 N VAL B 5 SHEET 3 AA4 5 VAL B 135 VAL B 139 -1 N VAL B 135 O LEU B 166 SHEET 4 AA4 5 ALA B 209 VAL B 213 -1 O SER B 210 N ALA B 136 SHEET 5 AA4 5 GLY B 114 GLU B 117 -1 N VAL B 116 O SER B 211 SHEET 1 AA5 5 ALA B 4 ASP B 6 0 SHEET 2 AA5 5 HIS B 162 ASN B 170 -1 O TYR B 169 N VAL B 5 SHEET 3 AA5 5 TYR B 177 LYS B 181 -1 O LYS B 181 N LEU B 165 SHEET 4 AA5 5 TYR B 193 ALA B 197 -1 O ILE B 196 N TRP B 178 SHEET 5 AA5 5 VAL B 151 MET B 152 1 N MET B 152 O ALA B 197 SHEET 1 AA6 2 ALA B 82 TYR B 84 0 SHEET 2 AA6 2 VAL B 108 THR B 111 -1 O ALA B 110 N VAL B 83 SSBOND 1 CYS A 22 CYS A 63 1555 1555 2.06 SSBOND 2 CYS A 56 CYS A 101 1555 1555 2.19 SSBOND 3 CYS A 155 CYS A 203 1555 1555 2.06 SSBOND 4 CYS B 22 CYS B 63 1555 1555 2.04 SSBOND 5 CYS B 56 CYS B 101 1555 1555 2.18 SSBOND 6 CYS B 155 CYS B 203 1555 1555 2.05 LINK SG CYS A 25 C22 2V5 A 301 1555 1555 1.89 LINK SG CYS B 25 C22 2V5 B 301 1555 1555 1.92 SITE 1 AC1 21 GLN A 19 GLY A 23 CYS A 25 TRP A 26 SITE 2 AC1 21 SER A 61 CYS A 63 GLY A 65 GLY A 66 SITE 3 AC1 21 LEU A 67 ALA A 138 MET A 145 LEU A 160 SITE 4 AC1 21 ASP A 161 HIS A 162 TRP A 184 GLU A 208 SITE 5 AC1 21 HOH A 573 HOH A 588 HOH A 638 ASP B 161 SITE 6 AC1 21 2V5 B 301 SITE 1 AC2 24 ASP A 161 2V5 A 301 GLN B 19 GLY B 23 SITE 2 AC2 24 SER B 24 TRP B 26 ALA B 27 PHE B 28 SITE 3 AC2 24 SER B 29 SER B 61 CYS B 63 GLY B 65 SITE 4 AC2 24 GLY B 66 LEU B 67 ALA B 138 MET B 145 SITE 5 AC2 24 LEU B 160 ASP B 161 HIS B 162 GLY B 163 SITE 6 AC2 24 TRP B 184 GLU B 208 HOH B 494 HOH B 608 CRYST1 133.923 38.669 94.646 90.00 113.91 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007467 0.000000 0.003311 0.00000 SCALE2 0.000000 0.025860 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011558 0.00000